Eleonora De Felice

Eleonora De Felice

Auto-generated profile, based on publicly available information

Eleonora De Felice

Department of Physiology and Pharmacology, Sapienza University, Rome, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
FMFrancesco Marrocco
Francesco Marrocco
MCMary Delli Carpini
Mary Delli Carpini
SGStefano Garofalo
Stefano Garofalo
Ottavia GiampaoliOttavia Giampaoli
Ottavia Giampaoli
EFEleonora De Felice
Eleonora De Felice
CLCristina Limatola
Cristina Limatola
Gut microorganisms and the products of their metabolism thoroughly affect host brain development, function and behavior. Since alterations of brain plasticity and cognition have been demonstrated upon motor, sensorial and social enrichment of the housing conditions, we hypothesized that gut microbiota and metabolome could be altered by environmental stimuli, providing part of the missing link among environmental signals and brain effects. In this preliminary study, metagenomic and metabolomic analyses of mice housed in different environmental conditions, standard and enriched, identify environment-specific microbial communities and metabolic profiles. We show that mice housed in an enriched environment have distinctive microbiota composition with a reduction in gut bacterial richness and biodiversity and are characterized by a metabolomic fingerprint with the increase of formate and acetate and the decrease of bile salts. We demonstrate that mice treated with a mixture of formate and acetate recapitulate some of the brain plasticity effects modulated by environmental enrichment, such as hippocampal neurogenesis, neurotrophin production, short-term plasticity and cognitive behaviors, that can be further exploited to decipher the mechanisms involved in experience-dependent brain plasticity.

Verified
Journal Article
Open access
PDF file
PCPierangelo Cifelli
Pierangelo Cifelli
GRGabriele Ruffolo
Gabriele Ruffolo
EFEleonora De Felice
Eleonora De Felice
VAVeronica Alfano
Veronica Alfano
EVErwin van Vliet
Erwin van Vliet
EPEleonora Palma
Eleonora Palma
γ-Aminobutyric acid type A receptors (GABAARs) are the main inhibitory mediators in the central nervous system (CNS). GABAARs are pentameric ligand gated ion channels, and the main subunit composition is usually 2α2βγ, with various isotypes assembled within a set of 19 different subunits. The inhibitory function is mediated by chloride ion movement across the GABAARs, activated by synaptic GABA release, reducing neuronal excitability in the adult CNS. Several studies highlighted the importance of GABA-mediated transmission during neuro-development, and its involvement in different neurological and neurodevelopmental diseases, from anxiety to epilepsy. However, while it is well known how different classes of drugs are able to modulate the GABAARs function (benzodiazepines, barbiturates, neurosteroids, alcohol), up to now little is known about GABAARs and cannabinoids interaction in the CNS. Endocannabinoids and phytocannabinoids are lately emerging as a new class of promising drugs for a wide range of neurological conditions, but their safety as medication, and their mechanisms of action are still to be fully elucidated. In this review, we will focus our attention on two of the most promising molecules (Δ9-tetrahydrocannabinol; Δ9-THC and cannabidiol; CBD) of this new class of drugs and their possible mechanism of action on GABAARs.

1 July 2020 in Neuroscience
Verified
Journal Article
Closed access
GRGabriele Ruffolo
Gabriele Ruffolo
PCPierangelo Cifelli
Pierangelo Cifelli
CMCatarina Miranda-Lourenço
Catarina Miranda-Lourenço
EFEleonora De Felice
Eleonora De Felice
CLCristina Limatola
Cristina Limatola
EPEleonora Palma
Eleonora Palma

30 March 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
PCPierangelo Cifelli
Pierangelo Cifelli
SILVIA DI ANGELANTONIOSILVIA DI ANGELANTONIO
SILVIA DI ANGELANTONIO
VAVeronica Alfano
Veronica Alfano
AMAlessandra Morano
Alessandra Morano
EFEleonora De Felice
Eleonora De Felice
EPEleonora Palma
Eleonora Palma
GABAA receptors-(Rs) are fundamental for the maintenance of an efficient inhibitory function in the central nervous system (CNS). Their dysfunction is associated with a wide range of CNS disorders, many of which characterized by seizures and epilepsy. Recently, an increased use-dependent desensitization due to a repetitive GABA stimulation (GABAA current rundown) of GABAARs has been associated with drug-resistant temporal lobe epilepsy (TLE). Here, we aimed to investigate the molecular determinants of GABAA current rundown with two different heterologous expression systems (Xenopus oocytes and human embryonic kidney cells; HEK) which allowed us to manipulate receptor stoichiometry and to study the GABAA current rundown on different GABAAR configurations. To this purpose, we performed electrophysiology experiments using two-electrode voltage clamp in oocytes and confirming part of our results in HEK. We found that different degrees of GABAA current rundown can be associated with the expression of different GABAAR β-subunits reaching the maximum current decrease when functional α1β2 receptors are expressed. Furthermore, the blockade of phosphatases can prevent the current rundown observed in α1β2 GABAARs. Since GABAAR represents one important therapeutic target in the treatment of human epilepsy, our results could open new perspectives on the therapeutic management of drug-resistant patients showing a GABAergic impairment.

23 September 2026 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
EFEleonora De Felice
Eleonora De Felice
GSGiovanni Signorini
Giovanni Signorini
LBLaura Bertarini
Laura Bertarini
MCMiriam Ciani
Miriam Ciani
GRGiovanna Rigillo
Giovanna Rigillo
SASilvia Alboni
Silvia Alboni